1. Home
  2. MBBC vs FEMY Comparison

MBBC vs FEMY Comparison

Compare MBBC & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MBBC

Marathon Bancorp Inc.

HOLD

Current Price

$14.00

Market Cap

33.5M

Sector

Finance

ML Signal

HOLD

Logo Femasys Inc.

FEMY

Femasys Inc.

N/A

Current Price

$0.52

Market Cap

37.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MBBC
FEMY
Founded
1902
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.5M
37.2M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
MBBC
FEMY
Price
$14.00
$0.52
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$5.50
AVG Volume (30 Days)
1.8K
381.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
8.60
EPS
N/A
N/A
Revenue
N/A
$1,629,108.00
Revenue This Year
N/A
$64.02
Revenue Next Year
N/A
$147.19
P/E Ratio
$47.11
N/A
Revenue Growth
N/A
51.97
52 Week Low
$9.94
$0.31
52 Week High
$14.64
$1.76

Technical Indicators

Market Signals
Indicator
MBBC
FEMY
Relative Strength Index (RSI) 61.97 42.05
Support Level $10.05 $0.47
Resistance Level N/A $0.58
Average True Range (ATR) 0.25 0.04
MACD 0.02 0.00
Stochastic Oscillator 66.14 30.35

Price Performance

Historical Comparison
MBBC
FEMY

About MBBC Marathon Bancorp Inc.

Marathon Bancorp Inc is a mid-tier holding company for Marathon Bank, a Wisconsin-chartered savings bank. The group operates as a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the group's revenue comes from interest income on loans and debt securities.

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Share on Social Networks: